Govt panel seeks additional data from SII, says Covovax not yet been approved in country of origin
An expert panel of India’s Central Drug Authority, which recently reviewed Serum Institute’s application seeking emergency authorisation of COVID-19 vaccine Covovax, has sought additional data from the firm, while noting the jab has not yet been approved…
